CureBay's Tech-Powered Network Revolutionizing Rural Healthcare Posts 8x Growth,First Circle Hits Profitability

CureBay, a hybrid healthcare platform transforming last-mile access to affordable, high-quality healthcare in underserved areas of India, has recorded an impressive 8x growth in GMV during H1 FY25 compared to H1 FY24. The company has reached an Annual Recurring Revenue (ARR) of INR 1,284 million and is on track to achieve INR 2,000 million by March 2025, driving meaningful impact in India’s $45 billion rural healthcare market. Committed to making quality healthcare accessible and affordable for all, CureBay operates over 150 eClinics and collaborates with 1,500 Digital Franchisees (Swasthya Mitras). Leveraging technology, the platform offers full-stack healthcare services—from consultations and diagnostics to tertiary care—bridging critical care gaps and ensuring holistic patient management in the most remote and underserved areas.

"What we're witnessing is not just growth in numbers, but a fundamental transformation in rural healthcare delivery," said Priyadarshi Mohapatra, Founder and CEO of CureBay. "Our network of world-class e-Clinics, powered by an intelligent tech platform and operated by trained, certified health workers, has profiled over 1.4 million patients, with a 20% conversion rate into active users. Additionally, 14% of these users have adopted preventive care memberships, reflecting the strong trust and engagement we’ve built in these communities. Achieving operational profitability in the Puri Circle of Odisha affirms our vision of delivering quality healthcare to every village, demonstrating that rural India is prepared to embrace technology-driven healthcare solutions."

CureBay continues to grow steadily, serving approximately 55,000 patients each quarter and enrolling 18,000 members in its subscription-based healthcare plans. Currently reaching over 18 million people across Odisha and Chhattisgarh, the company aims to extend its services to 100 million rural residents across 16 regions in six states: Odisha, Chhattisgarh, Jharkhand, Bihar, Uttar Pradesh, and Madhya Pradesh. To support this vision, CureBay is developing one of India’s largest rural health databases, leveraging AI and data monetization strategies, attracting interest from global healthcare platforms for data-sharing collaborations.

Through a hybrid healthcare model integrating micro-satellite centres, Swasthya Mitras, and a network of skilled providers, CureBay ensures that even remote communities can access timely medical services. The company's eClinics serve as strategically positioned hubs, equipped to offer basic check-ups, first aid, health education, diagnostics, and referrals. Trained local health workers, known as Swasthya Mitras, connect residents with medical consultations, diagnostics, and pharmacy services while creating economic opportunities for themselves.

CureBay's impact at the grassroots level is already evident in the Puri Circle of Odisha, where it covers 13% of the catchment population. The company's entry into new states, such as Chhattisgarh, reaffirms its commitment to delivering affordable and high-quality healthcare to traditionally underserved areas. Through CureBay Quantum—its AI-powered healthcare ecosystem—CureBay provides deep insights into rural health trends, facilitating targeted outreach and personalised care. By integrating cohort analysis with disease demographics, CureBay’s advanced technology platform fine-tunes healthcare interventions, improving health outcomes while enhancing operational efficiency. This approach also drives high GMV per employee, highlighting the scalability and sustainability of CureBay's business model as it pioneers accessible healthcare solutions for rural India.

About CureBay:

Founded in 2021 by Priyadarshi Mohapatra, Shobhan Mahapatra, and Sanjay Swain, and led by industry veterans like President Vasant Nangia, CureBay is a trailblazing hybrid healthcare platform transforming last-mile access to affordable, high-quality healthcare in India’s underserved regions. CureBay offers a full spectrum of services, including doctor consultations, medication delivery, diagnostic tests, surgery facilitation, annual health memberships, and a concierge service that supports patients throughout their healthcare journey—from admission to discharge.

Leveraging their proprietary platform, CureBay connects patients with affordable and quality healthcare services, regardless of their location, income, or insurance status. The company's innovative hybrid online and physical healthcare and fulfilment model has been successfully implemented across more than 32 districts in Odisha and Chhattisgarh, with a network of over 150 eClinics and collaborations with over  300 service providers.

Since its inception, CureBay has served more than 3,84,000 patients across Odisha and Chattisgarh, demonstrating its commitment to making healthcare more equitable for the underserved.

Toyota Kirloskar Motor Celebrates 1 Lakh Urban Cruiser Hyryder On Indian Road

Toyota Kirloskar Motor (TKM) today announced that the Urban Cruiser Hyryder has surpassed the remarkable milestone of 1,00,000-unit sales in India. This achievement underscores the B-SUV’s strong market acceptance and Indian customers growing acceptance of hybrid technology.

Launched in July 2022, the Urban Cruiser Hyryder seamlessly combines Toyota’s world-class hybrid technology with dynamic design, premium comfort, and exceptional performance. It is available in three powertrains- Self-charging Strong Hybrid Electric [SHEV], Neo Drive and CNG powertrains.

At the heart of the Urban Cruiser Hyryder is its 1.5-litre Engine with THS (Toyota Hybrid System) & e-drive transmission, delivering combined power output of 85 kW. Hyryder ’s hybrid system eliminates the need for external charging, ensuring convenience for customers at all times. Its cutting-edge hybrid system offers a seamless and silent drive, complemented by instant power delivery. This, combined with its responsive performance and quieter operation, provides an environmentally conscious yet dynamic driving experience. Additionally, Customers seeking versatility and power have also embraced the Neo Drive powertrain, which comes with an optional All-Wheel Drive (AWD) system—offering a superior driving experience for both urban commutes and challenging terrains.

The Urban Cruiser Hyryder is designed to deliver exceptional value, seamlessly combining advanced convenience and performance features with outstanding fuel efficiency. Reflecting TKM’s commitment to sustainable mobility, the SUV offers class-leading mileage: up to 27.97 km/l* in the Self Charging Hybrid Electric Vehicle variant, 21.12 km/l* in the NeoDrive (MT), and 26.6 km/kg* in CNG mode.

Commenting on the milestone, Mr. Sabari Manohar – Vice President, Sales-Service-Used Car Business, Toyota Kirloskar Motor said, “The positive response to the Urban Cruiser Hyryder reflects our commitment to delivering innovative mobility solutions tailored to the evolving preferences of Indian customers. This milestone is not just a number; it signifies the beginning of a new era in SUV technology that prioritizes sustainability, performance, and customer satisfaction. The Urban Cruiser Hyryder continues to uphold Toyota’s legacy of driving change through innovation and environmental consciousness, and we are deeply grateful for the trust our customers have placed in us. We extend our heartfelt gratitude to our customers who have been instrumental in achieving this milestone.”

The success and market acceptance of the Urban Cruiser Hyryder is further complemented with Toyota’s exceptional and industry-leading service benefits to the customers.  TKM provides a comprehensive range of services under the umbrella “T CARE” that demonstrates the company’s dedication to enriching customer delight and fostering long-term relationships. Covering everything from presales to aftersales and repurchases, T CARE integrates these offerings under one unified brand that includes a wide array of offerings such as T DELIVER, T GLOSS, T ASSIST, T SAATH, T SECURE, T CHOICE, T INSPECT, T SMILE and more.

Recently, Toyota Kirloskar Motor also celebrated the remarkable milestone of 1,00,000 units sold for the Innova HyCross, underscoring the immense trust Indian customers have placed in the brand. As TKM celebrates this new milestone of the Hyryder, the company remains committed to redefining sustainable mobility in India with innovative and reliable products that align with the aspirations of dynamic Indian customers.

Unnati Coffee Partners With Tribal Communities In Odisha To Promote Sustainable Agriculture And Ecotourism

In the heart of Odisha’s Koraput district, a pioneering initiative is changing the lives of tribal communities of village Padalput by integrating sustainable coffee farming with ecotourism. Project Unnati Coffee, a partnership between ISWAR (Integrated Social Welfare and Research Centre) and Coca-Cola India is helping the tribal village of Punjishil, 500 km from Bhubaneshwar, home to 45 families of the Paroja tribe, build a sustainable source of income while preserving its rich biodiversity. This innovative approach is improving livelihoods and creating a new model of economic growth that is rooted in environmental stewardship and community empowerment.

Recognizing opportunities, ISWAR started working with the Paroja tribe, integrating sustainable coffee farming with ecotourism. We provided training and resources to help villagers cultivate coffee sustainably on the biodiverse land surrounding their village. Young tribals were trained as guides and are now leading treks through the coffee plantations and forest trails, offering travelers insights into coffee cultivation. The tribal families opened their homes to visitors, offering traditional meals and overnight stays, creating a bridge between cultures while providing a stable income for the village.

Piyush Ranjan Mishra, CEO, ISWAR, said: "Project Unnati Coffee has not only improved livelihoods but also inspired the community to embrace sustainable practices. By integrating coffee farming with ecotourism, we’ve seen a transformation in Punjishil. This initiative is enhancing productivity and quality, strengthening the Farmers Producer Organization, and creating strong market linkages. Together we are building a model that benefits not just farmers but the local economy at large.”

What sets Project Unnati Coffee apart is its focus on empowering women and promoting community-driven leadership. Women in Punjishil have are managing key roles in coffee production, food services, and tourism operations. Through cooperatives, they’ve been able to generate a stable income, leading to better health, nutrition, and education within the village. Children who had to drop out of school to help their families are now attending school regularly, with a hope of having a brighter future.

"After a lot of hard work and setbacks, we struggled to get fruit from our coffee plants in the last few years. But after the training, the yield has been much better, and we’re hopeful for a good income this season. Given the success, we plan to plant coffee across all the hillocks next season." – Tulabati Badanayak, a tribal farmer from Koraput.

Project Unnati Coffee exemplifies how sustainable development can positively impact both local communities and the environment. By combining agriculture with tourism, this initiative offers a model for other tribal communities across India to thrive while preserving their natural resources.

About ISWAR:

Integrated Social Welfare and Research Centre (ISWAR) a Non-profit Organization, registered under Societies Registration Act, is established in the year 1994. ISWAR has the prime focus to work in the direction of improving the inclusive quality of lives of the resource poor families. It is involved in a wide thematic spread ranging from Climate Action, Reduction of Carbon Footprints, Natural Resource Management, Livelihood Promotion, Value Chain Development, Health, Education and Gender Mainstreaming.

About Project Unnati:

The project is part of Coca-Cola India’s Fruit Circular Economy initiative, which is a key pillar of the Company’s ESG priorities – Sustainable Agriculture. Project Unnati aims to support the Indian agri-ecosystem by enhancing farming efficiency, strengthening forward linkages, and building food-processing capacity in the country. Over more than a decade, Project Unnati has helped empower and enable over lakhs of farmers across 13 states and Union Territories in India. Focused on seven crop varieties Mango, Apple, Orange, Grapes, Litchi, Coffee, and sugarcane, the program is aimed at propelling the horticulture supply chain and building agriculture production capacities across the country.

Medtronic Launches The FDA Approved InterStim X™ Sacral Nerve Stimulation Therapy For Bladder Control And Bowel Control In India

* The new InterStim X™ Sacral neuromodulation system is a minimally invasive advanced therapy for managing urge urinary incontinence, urinary retention and fecal incontinence. The InterStim X system provides 10 to 15  years of battery life without the need to recharge.

Medtronic, a global leader in healthcare technology, announced the India launch of the InterStim X™ Sacral Neuromodulation (SNM) system for the treatment of overactive bladder (OAB), chronic fecal incontinence (FI), and non-obstructive urinary retention. The InterStim X™ system offers personalized sacral nerve stimulation therapy.

Sacral neuromodulation is an advanced therapy for people with bladder and bowel control issues that are not responding to other non-invasive therapies. The system works by targeting nerve signals that regulate bladder functions, which may reduce symptoms of incontinence – such as frequent trips to the bathroom and accidents. Patients can try the InterStim™ X system with an evaluation phase before they decide to have the system implanted, and it's reversible if they change their Sacral neuromodulation procedure is performed in two stages. During the first stage, the lead is implanted and connected to an external stimulator to check therapeutic response for a period of 3-5 days. In stage II, the lead is connected to a subcutaneous implantable pulse generator (IPG) which is like a pacemaker. The IPG sends electrical signals via the lead which then signals the brain for voiding and control. 

The InterStim™ X device and systems features: 

·       Proprietary 5th generation battery that offers more than 10 years of battery life without the need to recharge. With low energy settings, the device can last up to 15 years. 

·       The smart programmer is a device that resembles a common smartphone and has the capability of allowing patients to discreetly and independently adjust their choice of 11 therapy settings at home or on-the-go. 

·       SureScan™ technology that enables full body 1.5T and 3T MRI scans under certain conditions, which means that the latest imaging techniques can be availed when needed to diagnose disease, plan treatment, and monitor treatment progress. The MRI mode can be easily activated or deactivated by the patient using the smart programmer under the guidance of their physician.

“Medtronic is committed to advancing the standard of care of bladder and bowel control treatment and improving patient outcomes,” said Prateek Tiwari, Sr Director - Neuroscience & Specialty Therapies, Medtronic India. “With the introduction of the new recharge-free InterStim X, patients can get a decade or more of treatment for their bladder or bowel control issues from the only SNM system to be backed by over 90 clinical studies and over 1,000 clinical articles. It has been our endeavor to expand access to proven nerve stimulation therapies for the benefit of Indian patients with bladder and bowel control issues.”

About Medtronic

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.

Molbio Diagnostics Strengthens Leadership, Welcomes Distinguished Public Health Advocates To Its Board

~ Strategic appointments reinforce Molbio's commitment to advancing diagnostics and bridging healthcare gaps globally ~

Molbio Diagnostics, a pioneer in global healthcare based in Goa, is proud to announce the appointment of two new Independent Directors to its board, Professor (Dr.) Balram Bhargava and Dr. Arun Kumar Jha. These appointments come as the company continues to strengthen its Leadership and make significant strides in healthcare accessibility with its innovative solutions that cater to the remotest regions globally.

Professor (Dr.) Balram Bhargava is a leader in the public health sector with over 35 years of experience in medical research and health system strengthening. His previous roles include Director-General of the Indian Council of Medical Research and Secretary of India’s Department of Health Research, being at the forefront of managing several public health crises in India. Dr. Bhargava’s ongoing work in pandemic preparedness and health policy has been instrumental in promoting affordable healthcare innovations. His leadership at the National Academy of Sciences and numerous other institutions showcases his commitment to enhancing health outcomes worldwide.

"I am honoured to join the board of Molbio Diagnostics, a company that is at the forefront of diagnostic innovation and global health impact. The opportunity to contribute to Molbio’s mission aligns perfectly with my lifelong commitment to enhancing health through affordable and accessible healthcare solutions. I look forward to bringing my experience in medical research and health policy to further Molbio's efforts in revolutionizing point-of-care diagnostics and advancing global healthcare standards," said Professor (Dr.) Bhargava.

Dr. Arun Kumar Jha brings a wealth of experience in public health and policy, including his role as an Adviser in the Department of Economic Affairs, Ministry of Finance, and as an Economic Adviser in the Department of Health & Family Welfare, Ministry of Health & Family Welfare. He is currently working as the Hon'ble Chancellor of the National Institute of Advanced Manufacturing Technology (NIAMT) and Senior Adviser in John Snow India Pvt. Ltd. With his active involvement with the Government of India in schemes and programs that focus on tuberculosis elimination in the country, Dr. Jha has recently signed up an assignment with the Stop TB Partnership and United Nations Office for Project Services (UNOPS), positioning him as an invaluable asset in advancing Molbio’s mission to support global health initiatives.

"Joining Molbio Diagnostics as an Independent Director is a significant step in my continued advocacy for public health and policy reform. With Molbio’s innovative Truenat® platform, I see a tremendous potential to bridge healthcare gaps and improve disease management worldwide,” Dr. Jha expressed his enthusiasm. “Looking forward to being part of this transformative journey and supporting Molbio’s strategic vision in making a lasting impact on global health, particularly in underserved regions

"These appointments reflect Molbio Diagnostics’ commitment to bringing on board leaders who are at the forefront of healthcare innovation and public health policy," said Mr. Sriram Natarajan, Director and CEO of Molbio Diagnostics. "Dr. Jha and Dr. Bhargava’s impressive backgrounds and shared dedication to improving healthcare access aligns perfectly with our vision of transforming global health landscapes."

Molbio Diagnostics remains dedicated to its mission of enhancing healthcare accessibility through innovative diagnostics solutions. The inclusion of Dr. Jha and Dr. Bhargava on the board is expected to further strengthen the company’s impact on global health.

About Molbio Diagnostics:

Molbio Diagnostics Pvt. Ltd. is a leader in revolutionizing point-of-care diagnostics globally. With a commitment to providing rapid, reliable, and robust diagnostic solutions, Molbio brings advanced healthcare technologies to the last mile. The company's flagship Truenat®? real-time PCR platform is globally recognized and endorsed by the World Health Organization (WHO), enhancing infectious disease management worldwide. Molbio is dedicated to improving healthcare accessibility and quality with innovative diagnostics that meet global standards. For more information about Molbio Diagnostics and its initiatives, visit https://www.molbiodiagnostics.com/

Muthoot Finance Transformed 0.6 Million Lives Through Investment In Healthcare, Education, And Sustainability As Part Of CSR In Last Fiscal

Muthoot Finance, India’s largest gold loan NBFC continued to strengthen its commitment to socio-economic development through its Muthoot Social Responsibility (MSR) initiatives in FY 2023-24. During FY24, the company spent more than Rs. 1000 million in various community-focused projects, positively impacting the lives of more than 0.6 million people through a comprehensive and multi-faceted approach.

Continuing the legacy since the inception of The Muthoot Group in 1887, uplifting the society and fostering sustainability are deeply ingrained in Muthoot Finance’s organizational DNA. The CSR initiatives were focused on offering holistic development by focusing on key areas such as healthcare, education, livelihood support, renewable energy, promoting sports talent, supporting artists of India, wildlife conservation and other infrastructural development. The initiatives were spread across all states and union territories.

Muthoot Finance’s CSR activities also align with almost 12 of the United Nations Sustainable Development Goals (UNSDGs), including UNSDG 1 (No Poverty), UNSDG 2 (Zero Hunger), UNSDG 3 (Good Health and Well-being), UNSDG 4 (Quality Education) amongst many others. With education as one of the primary focus area, the company is proud to report that about 75% of its CSR budget was spent on bridging the educational gap for talented yet underserved children in the country. The initiatives included construction of new academic institution infrastructure, donation of school stationery, construction and renovation of Smart Anganwadis, higher education scholarships amongst others. Almost, Rs. 10 crores were spent on supporting sports activities and sportsmen to represent India in global events. Muthoot Finance further extended its support to a plethora of species of flora and fauna at Tipeshwar Wildlife Sanctuary and Melghat Tiger Reserve by installing solar pumps. This helps in combating challenges posed by climate change and providing consistent water supply throughout the year.

Mr. George Muthoot George, Deputy Managing Director, Muthoot Finance, said, “As a strong believer of the values and ethos of The Muthoot Group of giving it back to society, we are happy that we were able to make a small difference at our end in FY24. Aligned with our three focus areas – Education, Healthcare, and Environment – we are emphasizing on multiple initiatives to lay the groundwork for solving a myriad of various issues. The key objective behind our CSR initiatives is to be a catalyst for social development, contributing to sustainable economic growth of India, and further creating an Atmanirbhar Bharat. As a trusted NBFC, we will continue to prioritize programs and initiatives to enhance economic and social well-being, striving for a harmonious balance between corporate practices and community welfare.”

Under the series of these initiatives, some notable activities included:

*        Healthcare: Muthoot Finance aims to contribute significantly towards strengthening India’s healthcare framework. As part of its flagship healthcare initiative - Muthoot Snehashreya, Muthoot Finance touched the lives around one-lakh beneficiaries by helping them with prevention and early detection of kidney-related diseases, diabetes, and hypertension ailments. Additionally, on the account of World Tuberculosis Day, Muthoot Finance in association with Samartha Sahakari Trust and Primary Health Centre Ekkur distributed nutritional kits to various identified TB patients in the Mangalore region. The company celebrated World Health Day by offering free health checkups and medical kits to the people at the bottom of the pyramid. Further, the company also distributed bunker cots and bed mattresses along with pillows to Government Annai Sathya Orphanage Home in Madurai. Distributed advanced microscopes to multiple government hospitals in Madurai with an objective of supporting the National TB Elimination and Control Program.

*        Education:  In association with Round Table India Association, established smart class facilities at seven identified Government Schools across Five Districts in TamilNadu benefitting more than 4000 students by radically improving their academic performance and enhancing the process of study. Provided Muthoot M George Higher Education Scholarship worth Rs. 10 crores to meritorious students pursuing professional degrees in MBBS, Engineering and BSc Nursing. In the 2023-24, Muthoot Finance recognised the academic achievements of more than a thousand students in 8th and 9th grade across key cities such as Bangalore, Chennai, Madurai, Mangalore, Mumbai, Delhi, Ernakulam, Kottayam and Alleppey. Muthoot Finance allocated more than Rs. 2 crores as part of school scholarships initiative.

*        Promoting sports: This segment gained significant prominence during the year. The company provided financial backing to multiple young athletes including professional cyclist Mr. Sreenath Lakshmikanth, and Ms. Sini K Sebastian to represent the nation at various National and International Championships. Both of the athletes were able to achieve remarkable success at their respective events. Additionally, in association with FICCI, Muthoot Finance organized Corporate Sports Championship Kochi 2023 by bringing together over 20 leading corporate firms, including major players such as EY, TCS, Lulu Group, and Geojit Financial Services amongst others to foster sportsmanship and unity within the corporate sector. To support the future generation, Muthoot Finance has dedicated budgets for improvement of sports infrastructure of various schools and colleges across the country. 

*         Improving quality of life: As part of this initiative, Muthoot Finance distributed wheelchairs, battery-operated tricycles and other medical mobility aids and appliance to over 200 differently abled people.  It conducted across cities including Delhi, Dadar amongst others with an aim to support their livelihood and allowing them greater access to social life and community engagement. Built a Virtual Reality Interactive Therapy Unit (Blueroom/Sensory room) for the Centre for Empowerment and Enrichment (CEFEE) in Kerala to create equal opportunities for specially abled children. Sewing machines were donated to the persons with disability (hearing impaired) at Nandini Devi Special School for the Deaf & Blind Akhyam Kalyan Samiti Dhenkanal District, Odisha.

*        Promoting arts and culture: Through our ‘Muthoot Snehasammanam’ initiative, the company supported 45 veteran artists who carry forward these unique cultural legacies since its inception in 2015. The programme provided essential financial assistance worth Rs. 27 Lakhs in FY24 and a cumulative spend of Rs. 70 Lakhs under this scheme so far.

*        Sustainable Livelihood support: Successfully constructed and handed over the newest tranche of 14 houses under the CSR initiative of Muthoot Aashiyana Housing Project in the coastal suburb of Edavanakkad located in Kochi. Distributed fishing utensils to around 200 fisherwomen in Colachel, Kanyakumari District to improve their fishing activities, positively contributing to the socioeconomic development of the region.

*        Environment: Installed solar pumps at Tipeshwar Wildlife Sanctuary and Melghat Tiger Reserve in collaboration with the Hope and Helping Hand Society NGO to safeguard natural ecosystems and wildlife habitats. Established a 25 KWp solar power plant in Kerala Museum to preserve the environment through sustainable manufacturing practices. Solar energy is contributing to 50% of the museum's electricity requirements and is helping in saving Rs. 5 Lakhs every year. Set up a Bio Medical Waste Storage Room at Government Hospital, Madurai District to enable the hospital to effectively store, segregate and manage the bio waste accumulated on a daily basis.

About Muthoot Finance

Muthoot Finance is the flagship company of The Muthoot Group which has 20 diversified business divisions. With 6000+ branches, the Group serves over 2.5 Lac customers every day. Muthoot Finance is India’s largest gold loan NBFC and India’s No.1 Most Trusted Financial Services Brand, according to the Brand Trusted Report. It is a reputed ‘Systemically Important Non-deposit taking NBFC’. As part of the core business, Muthoot Finance provides loans secured against household gold jewellery at highly affordable rates and amazing product features. Globally, the Group has presence across, USA, UK, UAE, Costa Rica, Nepal and Sri Lanka. For more details visit: www.muthootfinance.com

Trustwell Hospital Successfully Performs Life-Saving Bone Marrow Transplant For Young Man

Trustwell hospital is proud to announce the successful completion of a bone marrow transplant for Raghu (name changed). Raghu, young man, pleasant Office Executive, was diagnosed as relapsed extramedullary B-cell Acute Lymphoblastic Leukaemia (ALL), which is a type of blood cancer. Originally diagnosed with B-cell ALL in 2019, he was initially treated with chemotherapy but unfortunately the  disease relapsed in March 2024. Subsequently he was given the second round of chemotherapy and was planned for a bone marrow transplant to give him the best chance of cure. A haploidentical allogeneic bone marrow transplant was performed on October 19, 2024, with his sister as the donor. He had to be admitted in the hospital for a total of 28 days, whereby he received the conditioning regimen and post-transplant care. He was then discharged and is currently under follow-up care with us.

The transplant was performed by Dr Sachin Jadhav MBBS, MD, DM Clinical Haematology & Dr Nishit MBBS, MD, Clinical lead Haematology & BMT and a team of specialized medical professionals dedicated to advanced treatments in hematological diseases. The doctor said, "despite age on his side the patient was a huge challenge for us. More so the relapsed case we were extra cautious and handled him with care & precision. This was our plus point which worked well & we are glad that he can lead normal life going forward." “The courage demonstrated by our patient is nothing short of inspiring,” said Dr. Nishit. “With every transplant, we strive to not only extend lives but improve the quality of life for our patients.”

Finding a Match

The search for a compatible bone marrow donor was crucial to the transplant’s success and was very seamless as the sister was the donor . The medical team worked tirelessly to coordinate logistics, funding and treatment to ensure that the procedure met the highest standards of safety and care.

The Journey to Recovery

Following the transplant, Raghu (name changed) has shown promising signs of recovery. Over the coming weeks, he will continue to be closely monitored by our medical team for potential complications, such as infections and graft-versus-host disease.

“This procedure reflects our ongoing commitment to cutting-edge treatment and compassionate patient care. Over the years our team has ensured that the chances of success are at par with international hospitals. After all, it takes immense dedication from doctors, nurses, Clinical Pharmacologists and all the hospital supporting staff.” stated Dr. Sachin Jadhav. “We are optimistic about Raghu's progress and look forward to ensuring that he goes back to his normal life.”

About Trustwell Hospitals

Trustwell Hospital is a Multi-super specialty 250 bedded hospital in the heart of the city of Bangalore. Trustwell Hospital is a unique venture where the people who actually understand the needs of a patient are also the ones running it. Trustwell is a place where clinical experts in their chosen fields who have been constantly delivering quality medical care over several decades have come together to put up the best possible hospital infrastructure and also bring with them industry best practices to run such a place.